ASBM Shares International Perspectives, Australian Physician Insights with Australian Policymakers, Patient and Physician Groups

March 2, 2017

ASBM held a series of meetings in February with Australian regulators and policy makers, as well as pharmacy, physician and patient organizations. ASBM Executive Director Michael Reilly was joined by International Advisory Board member Stephen Murby, who is also the former head of the Consumers Health Forum. The primary purpose of these meetings was to […]

Read More


New research reveals how Australian physician confidence in prescribing biosimilars could be bolstered

February 16, 2017

  A leading authority on international biosimilar medicines policies today released new research that identifies key areas to improve Australian physicians’ confidence in prescribing biosimilar medicines.   The Alliance for Safe Biologic Medicines (ASBM), a non-profit organization, surveyed 160 Australian physicians who prescribe biologics from seven therapeutic specialties with respect to their beliefs and attitudes […]

Read More